NO20081892L - Polycykliske karbamoylpyridonderivat med HIV-integraseinhiberende aktivitet - Google Patents
Polycykliske karbamoylpyridonderivat med HIV-integraseinhiberende aktivitetInfo
- Publication number
- NO20081892L NO20081892L NO20081892A NO20081892A NO20081892L NO 20081892 L NO20081892 L NO 20081892L NO 20081892 A NO20081892 A NO 20081892A NO 20081892 A NO20081892 A NO 20081892A NO 20081892 L NO20081892 L NO 20081892L
- Authority
- NO
- Norway
- Prior art keywords
- optionally substituted
- lower alkyl
- heterocyclic group
- hydrogen
- inhibitory activity
- Prior art date
Links
- 108010002459 HIV Integrase Proteins 0.000 title abstract 2
- 230000002401 inhibitory effect Effects 0.000 title abstract 2
- -1 Polycyclic carbamoylpyridone derivatives Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 8
- 125000000623 heterocyclic group Chemical group 0.000 abstract 5
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000005346 substituted cycloalkyl group Chemical group 0.000 abstract 4
- 150000002431 hydrogen Chemical class 0.000 abstract 3
- 125000003107 substituted aryl group Chemical group 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 239000002259 anti human immunodeficiency virus agent Substances 0.000 abstract 1
- 229940124411 anti-hiv antiviral agent Drugs 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005312076 | 2005-10-27 | ||
JP2006223875 | 2006-08-21 | ||
PCT/JP2006/321335 WO2007049675A1 (fr) | 2005-10-27 | 2006-10-26 | Dérivé de carbamoylpyridone polycyclique ayant une activité d'inhibition sur l'intégrase du vih |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20081892L true NO20081892L (no) | 2008-06-23 |
Family
ID=37967785
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20081892A NO20081892L (no) | 2005-10-27 | 2008-04-22 | Polycykliske karbamoylpyridonderivat med HIV-integraseinhiberende aktivitet |
Country Status (15)
Country | Link |
---|---|
US (2) | US8188271B2 (fr) |
EP (1) | EP1950212B1 (fr) |
JP (1) | JP5131689B2 (fr) |
KR (1) | KR20080064182A (fr) |
AU (1) | AU2006307101A1 (fr) |
BR (1) | BRPI0617842A2 (fr) |
CA (1) | CA2626956A1 (fr) |
EA (1) | EA200801144A1 (fr) |
ES (1) | ES2569357T3 (fr) |
IL (1) | IL190879A0 (fr) |
MA (1) | MA29879B1 (fr) |
MX (1) | MX2008005137A (fr) |
NO (1) | NO20081892L (fr) |
TW (1) | TW200800988A (fr) |
WO (1) | WO2007049675A1 (fr) |
Families Citing this family (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006116764A1 (fr) | 2005-04-28 | 2006-11-02 | Smithkline Beecham Corporation | Derive polycyclique de la carbamoylpyridone a activite inhibitrice sur l'integrase du vih |
CA2626956A1 (fr) | 2005-10-27 | 2007-05-03 | Shionogi & Co., Ltd. | Derive de carbamoylpyridone polycyclique ayant une activite d'inhibition sur l'integrase du vih |
US7482345B2 (en) * | 2005-12-05 | 2009-01-27 | Meng-Hsin Chen | P38 kinase inhibiting agents |
DK2220076T5 (da) | 2007-11-15 | 2012-09-17 | Gilead Sciences Inc | Inhibitorer af replikationen af humant immundefektvirus |
RU2503679C2 (ru) | 2007-11-15 | 2014-01-10 | Джилид Сайенсиз, Инк. | Ингибиторы репликации вируса иммунодефицита человека |
EA201200631A1 (ru) | 2007-11-16 | 2012-11-30 | Джилид Сайенсиз, Инк. | Ингибиторы репликации вируса иммунодефицита человека |
EP2320909B8 (fr) * | 2008-07-25 | 2016-03-30 | VIIV Healthcare Company | Composés chimiques |
ES2964383T3 (es) | 2008-12-11 | 2024-04-05 | Viiv Healthcare Co | Procesos e intermedios para inhibidores de la integrasa del VIH de carbamoilpiridona |
MX2011006241A (es) | 2008-12-11 | 2011-06-28 | Shionogi & Co | Sintesis de inhibidores de integrasa de vih de carbamoil-piridona e intermediarios. |
TWI518084B (zh) | 2009-03-26 | 2016-01-21 | 鹽野義製藥股份有限公司 | 哌喃酮與吡啶酮衍生物之製造方法 |
PT2444400T (pt) | 2009-06-15 | 2018-06-06 | Shionogi & Co | Derivado de carbamoilpiridona policíclico substituído |
EP2488521B1 (fr) * | 2009-10-13 | 2013-12-18 | Elanco Animal Health Ireland Limited | Inhibiteurs de l'intégrase macrocyclique |
WO2011105590A1 (fr) * | 2010-02-26 | 2011-09-01 | 日本たばこ産業株式会社 | Dérivé de 1,3,4,8-tétrahydro-2h-pyrido[1,2-a]pyrazine et son utilisation comme inhibiteur d'intégrase de vih |
TWI582097B (zh) | 2010-03-23 | 2017-05-11 | Viiv醫療保健公司 | 製備胺甲醯吡啶酮衍生物及中間體之方法 |
JP5766690B2 (ja) * | 2010-04-12 | 2015-08-19 | 塩野義製薬株式会社 | インテグラーゼ阻害活性を有するピリドン誘導体 |
SI2620436T1 (en) | 2010-09-24 | 2018-08-31 | Shionogi & Co., Ltd. | A prodrug substituted polycyclic carbamoyl pyridone derivative |
US9200009B2 (en) | 2011-10-12 | 2015-12-01 | Shionogi & Co., Ltd. | Polycyclic pyridone derivative having integrase inhibitory activity |
PE20221914A1 (es) | 2011-12-28 | 2022-12-23 | Global Blood Therapeutics Inc | Compuestos de benzaldehido sustituidos y metodos para su uso en incrementar la oxigenacion del tejido |
EP2797597B1 (fr) | 2011-12-28 | 2020-02-26 | Global Blood Therapeutics, Inc. | Composés d'aldéhydes hétéroaryles substitués et leurs procédés d'utilisation dans l'accroissement de l'oxygénation tissulaire |
WO2014099586A1 (fr) * | 2012-12-17 | 2014-06-26 | Merck Sharp & Dohme Corp. | Dérivés 4-pyridinonetriazines en tant qu'inhibiteurs de l'intégrase du vih |
KR102527797B1 (ko) | 2012-12-21 | 2023-05-03 | 길리애드 사이언시즈, 인코포레이티드 | 폴리시클릭-카르바모일피리돈 화합물 및 그의 제약 용도 |
US20140221380A1 (en) * | 2012-12-27 | 2014-08-07 | Japan Tobacco Inc. | SUBSTITUTED SPIROPYRIDO[1,2-a]PYRAZINE DERIVATIVE AND PHARMACEUTICAL USE OF SAME AS HIV INTEGRASE INHIBITOR |
CN112500338A (zh) | 2013-03-15 | 2021-03-16 | 全球血液疗法股份有限公司 | 化合物及其用于调节血红蛋白的用途 |
US9604999B2 (en) | 2013-03-15 | 2017-03-28 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
AU2014237330A1 (en) | 2013-03-15 | 2015-09-17 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
KR101971385B1 (ko) | 2013-03-15 | 2019-04-22 | 글로벌 블러드 테라퓨틱스, 인크. | 헤모글로빈 조정을 위한 화합물 및 이의 용도 |
US20140274961A1 (en) | 2013-03-15 | 2014-09-18 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US10266551B2 (en) | 2013-03-15 | 2019-04-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US9458139B2 (en) | 2013-03-15 | 2016-10-04 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US9802900B2 (en) | 2013-03-15 | 2017-10-31 | Global Blood Therapeutics, Inc. | Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin |
US9422279B2 (en) | 2013-03-15 | 2016-08-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US8952171B2 (en) | 2013-03-15 | 2015-02-10 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US10100043B2 (en) | 2013-03-15 | 2018-10-16 | Global Blood Therapeutics, Inc. | Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation |
EP3008044B1 (fr) * | 2013-06-13 | 2018-11-21 | Merck Sharp & Dohme Corp. | Composés hétérocycliques tricycliques fusionnés utiles en tant qu'inhibiteurs de l'intégrase du vih |
NO2865735T3 (fr) | 2013-07-12 | 2018-07-21 | ||
CA2916993C (fr) | 2013-07-12 | 2019-01-15 | Gilead Sciences, Inc. | Composes polycycliques-carbomoylpyridone et leur utilisation pharmaceutique |
EA201992707A1 (ru) | 2013-11-18 | 2020-06-30 | Глобал Блад Терапьютикс, Инк. | Соединения и их применения для модуляции гемоглобина |
WO2015089847A1 (fr) | 2013-12-20 | 2015-06-25 | Merck Sharp & Dohme Corp. | Composés à hétérocycles spirocycliques utiles en tant qu'inhibiteurs d'intégrase du vih |
AU2015214182B2 (en) | 2014-02-07 | 2020-04-30 | Global Blood Therapeutics, Inc. | Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde |
NO2717902T3 (fr) | 2014-06-20 | 2018-06-23 | ||
TW201613936A (en) | 2014-06-20 | 2016-04-16 | Gilead Sciences Inc | Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide |
TWI744723B (zh) | 2014-06-20 | 2021-11-01 | 美商基利科學股份有限公司 | 多環型胺甲醯基吡啶酮化合物之合成 |
EP3196201B1 (fr) * | 2014-08-22 | 2021-04-28 | Shionogi & Co., Ltd. | Dérivé de pyridone polycyclique possédant une activité inhibitrice d'intégrase |
TWI695003B (zh) | 2014-12-23 | 2020-06-01 | 美商基利科學股份有限公司 | 多環胺甲醯基吡啶酮化合物及其醫藥用途 |
MA41841A (fr) | 2015-03-30 | 2018-02-06 | Global Blood Therapeutics Inc | Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs |
AU2016244035B2 (en) | 2015-04-02 | 2018-11-01 | Gilead Sciences, Inc. | Polycyclic-carbamoylpyridone compounds and their pharmaceutical use |
CA2984130C (fr) | 2015-04-28 | 2021-07-20 | Shionogi & Co., Ltd. | Derive de pyridone polycyclique substitue et promedicaments de celui-ci |
HRP20230215T1 (hr) | 2015-04-28 | 2023-04-14 | Shionogi & Co., Ltd. | Supstituirani policiklički derivati piridona i njihov predlijek |
WO2016187788A1 (fr) | 2015-05-25 | 2016-12-01 | Merck Sharp & Dohme Corp. | Composés hétérocycliques tricycliques fusionnés utiles pour traiter l'infection au vih |
MA43373A (fr) | 2015-12-04 | 2018-10-10 | Global Blood Therapeutics Inc | Régimes posologiques pour 2-hydroxy-6-((2- (1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)méthoxy)benzaldéhyde |
SG11201804348SA (en) | 2015-12-15 | 2018-06-28 | Shionogi & Co | Medicine for treating influenza characterized by comprising combination of cap-dependent endonuclease inhibitor with anti-influenza drug |
TWI663160B (zh) | 2016-05-12 | 2019-06-21 | 全球血液治療公司 | 用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法 |
CN110494141A (zh) | 2016-08-10 | 2019-11-22 | 盐野义制药株式会社 | 含有被取代的多环性吡啶酮衍生物及其前药的药物组合物 |
TW202332423A (zh) | 2016-10-12 | 2023-08-16 | 美商全球血液治療公司 | 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑 |
JOP20190130A1 (ar) | 2016-12-02 | 2019-06-02 | Merck Sharp & Dohme | مركبات حلقية غير متجانسة رباعية الحلقات مفيدة كمثبطات إنزيم مدمج لفيروس نقص المناعة البشرية (hiv) |
JP2020500866A (ja) * | 2016-12-02 | 2020-01-16 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | Hivインテグラーゼ阻害剤として有用な三環式複素環化合物 |
JP7027179B2 (ja) * | 2018-01-24 | 2022-03-01 | キヤノン株式会社 | 給送回転体、シート給送装置及び画像形成装置 |
WO2019160783A1 (fr) * | 2018-02-15 | 2019-08-22 | Merck Sharp & Dohme Corp. | Composés hétérocycliques tricycliques utiles en tant qu'inhibiteurs de l'intégrase du vih |
WO2019230857A1 (fr) * | 2018-05-31 | 2019-12-05 | 塩野義製薬株式会社 | Dérivé de pyridone polycyclique |
TWI820141B (zh) * | 2018-05-31 | 2023-11-01 | 日商鹽野義製藥股份有限公司 | 衍生物 |
CR20230571A (es) * | 2018-05-31 | 2024-01-22 | Shionogi & Co | DERIVADO POLICÍCLICO DE CARBAMOILPIRIDONA (divisional 2020-0644) |
EP3815689A4 (fr) * | 2018-06-27 | 2022-04-20 | National University Corporation Hokkaido University | Inhibiteur de la croissance d'arénavirus comprenant un dérivé de carbamoylpyridone polycyclique |
CN112996789A (zh) * | 2018-09-12 | 2021-06-18 | 诺华股份有限公司 | 抗病毒吡啶并吡嗪二酮化合物 |
WO2020072377A1 (fr) | 2018-10-01 | 2020-04-09 | Global Blood Therapeutics, Inc. | Modulateurs de l'hémoglobine pour le traitement de la drépanocytose |
EP4122537A1 (fr) | 2019-03-22 | 2023-01-25 | Gilead Sciences, Inc. | Composés tricycliques pontés de carbamoylpyridone et leur utilisation pharmaceutique |
US20200398978A1 (en) | 2019-06-20 | 2020-12-24 | Bell Helicopter Textron Inc. | Low-drag rotor blade extension |
JPWO2021107065A1 (fr) * | 2019-11-28 | 2021-06-03 | ||
US20230059640A1 (en) | 2019-11-28 | 2023-02-23 | Shionogi & Co., Ltd. | Prophylactic and therapeutic pharmaceutical agent for hiv infectious diseases characterized by comprising combination of integrase inhibitor and anti-hiv agent |
JP7361013B2 (ja) * | 2019-11-28 | 2023-10-13 | 塩野義製薬株式会社 | 多環性カルバモイルピリドン誘導体を含有する医薬組成物 |
US11697652B2 (en) | 2020-02-24 | 2023-07-11 | Gilead Sciences, Inc. | Tetracyclic compounds and uses thereof |
WO2022159387A1 (fr) | 2021-01-19 | 2022-07-28 | Gilead Sciences, Inc. | Composés de pyridotriazine substitués et leurs utilisations |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0296506A (ja) | 1988-09-30 | 1990-04-09 | Daicel Chem Ind Ltd | 除草剤組成物 |
JP2533796B2 (ja) | 1988-10-18 | 1996-09-11 | ダイセル化学工業株式会社 | 5−アルコキシピリジン−3−カルボキサミド誘導体とその製造方法及び植物成長抑制剤 |
JP2551472B2 (ja) | 1988-10-18 | 1996-11-06 | ダイセル化学工業株式会社 | 5−アルコキシ−γ−ピロン−3−カルボキサミド誘導体とその製造方法及び植物成長抑制剤 |
CZ20031028A3 (cs) * | 2000-10-12 | 2003-08-13 | Merck & Co., Inc. | Aza- a polyazanaftalenylkarboxamidy |
CN101513402B (zh) | 2001-08-10 | 2012-03-21 | 盐野义制药株式会社 | 抗病毒药 |
DE60218511T2 (de) | 2001-10-26 | 2007-10-25 | Istituto Di Richerche Di Biologia Molecolare P. Angeletti S.P.A. | Dihydroxypyrimidin-carbonsäueramid-hemmer der hiv-integrase |
US7300364B2 (en) | 2004-02-06 | 2007-11-27 | Acushnet Company | Multi-layer golf ball having velocity gradient from faster center to slower cover |
US7109186B2 (en) | 2002-07-09 | 2006-09-19 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
EP2045242A1 (fr) | 2002-08-13 | 2009-04-08 | Shionogi&Co., Ltd. | Composants hétérocycliques disposant d'une activité inhibitoire contre l'intégrase du HIV |
AU2003267098B2 (en) | 2002-09-11 | 2008-11-20 | Merck & Co., Inc. | Dihydroxypyridopyrazine-1,6-dione compounds useful as HIV integrase inhibitors |
EP1578748B1 (fr) | 2002-12-27 | 2010-09-15 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. | Tetrahydro-4h-pyrido[1,2-a]pyrimidines et composes connexes convenant comme inhibiteurs de l'integrase du vih |
JP2004244320A (ja) | 2003-02-10 | 2004-09-02 | Shionogi & Co Ltd | 含窒素複素環抗ウイルス剤 |
TW200510425A (en) | 2003-08-13 | 2005-03-16 | Japan Tobacco Inc | Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor |
WO2005087766A1 (fr) * | 2004-03-09 | 2005-09-22 | Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa | Inhibiteurs de l'intégrase du vih |
CA2634499A1 (fr) | 2004-12-23 | 2006-06-29 | Virochem Pharma Inc. | Hydroxydihydropyridopy razine-1,8-diones et procedes d'inhibition de l'integrase du vih |
EP1852434B1 (fr) | 2005-02-21 | 2011-07-13 | Shionogi Co., Ltd. | Dérivé de carbamoylpyridone bicyclique ayant une activité d'inhibition de la vih intégrase |
WO2006116764A1 (fr) * | 2005-04-28 | 2006-11-02 | Smithkline Beecham Corporation | Derive polycyclique de la carbamoylpyridone a activite inhibitrice sur l'integrase du vih |
JP2005312076A (ja) | 2005-05-26 | 2005-11-04 | Olympus Corp | 電子撮像装置 |
CA2626956A1 (fr) | 2005-10-27 | 2007-05-03 | Shionogi & Co., Ltd. | Derive de carbamoylpyridone polycyclique ayant une activite d'inhibition sur l'integrase du vih |
-
2006
- 2006-10-26 CA CA002626956A patent/CA2626956A1/fr not_active Abandoned
- 2006-10-26 WO PCT/JP2006/321335 patent/WO2007049675A1/fr active Application Filing
- 2006-10-26 AU AU2006307101A patent/AU2006307101A1/en not_active Abandoned
- 2006-10-26 JP JP2007542639A patent/JP5131689B2/ja active Active
- 2006-10-26 MX MX2008005137A patent/MX2008005137A/es not_active Application Discontinuation
- 2006-10-26 US US12/084,128 patent/US8188271B2/en not_active Expired - Fee Related
- 2006-10-26 EP EP06822311.4A patent/EP1950212B1/fr active Active
- 2006-10-26 TW TW095139466A patent/TW200800988A/zh unknown
- 2006-10-26 EA EA200801144A patent/EA200801144A1/xx unknown
- 2006-10-26 KR KR1020087012320A patent/KR20080064182A/ko not_active Application Discontinuation
- 2006-10-26 ES ES06822311.4T patent/ES2569357T3/es active Active
- 2006-10-26 BR BRPI0617842-1A patent/BRPI0617842A2/pt not_active IP Right Cessation
-
2008
- 2008-04-15 IL IL190879A patent/IL190879A0/en unknown
- 2008-04-22 NO NO20081892A patent/NO20081892L/no not_active Application Discontinuation
- 2008-04-23 MA MA30862A patent/MA29879B1/fr unknown
-
2012
- 2012-03-23 US US13/428,242 patent/US20120208998A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JPWO2007049675A1 (ja) | 2009-04-30 |
MA29879B1 (fr) | 2008-10-03 |
US20120208998A1 (en) | 2012-08-16 |
WO2007049675A1 (fr) | 2007-05-03 |
CA2626956A1 (fr) | 2007-05-03 |
EP1950212A1 (fr) | 2008-07-30 |
EA200801144A1 (ru) | 2008-10-30 |
ES2569357T3 (es) | 2016-05-10 |
MX2008005137A (es) | 2008-09-29 |
BRPI0617842A2 (pt) | 2011-08-09 |
EP1950212A4 (fr) | 2010-08-04 |
US20090143356A1 (en) | 2009-06-04 |
AU2006307101A1 (en) | 2007-05-03 |
TW200800988A (en) | 2008-01-01 |
KR20080064182A (ko) | 2008-07-08 |
JP5131689B2 (ja) | 2013-01-30 |
EP1950212B1 (fr) | 2016-02-24 |
US8188271B2 (en) | 2012-05-29 |
IL190879A0 (en) | 2008-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20081892L (no) | Polycykliske karbamoylpyridonderivat med HIV-integraseinhiberende aktivitet | |
RS54618B1 (en) | NEW S-NITROZOGLUTATION REDUCTASE INHIBITORS | |
EA201070994A1 (ru) | Конденсированное гетероциклическое производное и его применение | |
EA200600225A1 (ru) | Производные пиперазина для лечения вич инфекций | |
TW200642683A (en) | Heterocyclic compound | |
TW200637840A (en) | Compounds for inflammation and immune-related uses | |
BR0315405A (pt) | Compostos inibidores da integrase tricìclica pré-organizados | |
NO20085385L (no) | Tiazolforbindelser som cannabinoidreseptorligander og anvendelser derav | |
WO2009016462A3 (fr) | Bicyclolactames substitués | |
CR8755A (es) | Derivado de quinolina fusionada y uso del mismo | |
MX2007004699A (es) | Derivados de indol y bencimidazol. | |
WO2008108380A3 (fr) | Composés de pyrrole | |
ATE556058T1 (de) | 1-(2h)-isochinolonderivat | |
ATE508747T1 (de) | C-kit kinase-hemmer | |
MX2009007713A (es) | Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas. | |
UA96568C2 (en) | Polycyclic carbamoyl pyridone derivative as hiv-integrase inhibitor | |
WO2006100082A3 (fr) | Derives d'oxindole substitues, medicaments contenant ces derives et leur utilisation | |
TW200602319A (en) | Indole derivative and use thereof | |
WO2011004162A3 (fr) | Composés utilisés en tant que médicaments | |
RS51661B (en) | NEW DIOSMETHINE DERIVATIVES, THE PROCEDURE FOR THEIR MAKING AND THE PHARMACEUTICAL MIXTURES CONTAINING THEM | |
DK2032370T3 (da) | Reversible thermochrome sammensætninger | |
WO2007017728A3 (fr) | Nouveaux composes heterocycliques | |
NO20076145L (no) | Ureadeviater, fremgangsmater for deres fremstilling og anvendelse derav | |
TW200716571A (en) | Heterocyclic reverse transcriptase inhibitors | |
WO2009040314A3 (fr) | Nouveaux dérivés de l'acétone substitués par un hétéroaryle, appropriés comme inhibiteurs de la phospholipase a2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |